High-Fat Diet-Induced Alterations in the Feeding Suppression of Low-Dose Nisoxetine, a Selective Norepinephrine Reuptake Inhibitor
Central noradrenergic pathways are involved in feeding and cardiovascular control, physiological processes altered by obesity. The present studies determined how high-fat feeding and body weight gain alter the sensitivity to the feeding suppression and neural activation to a selective norepinephrine...
Saved in:
Main Authors: | Nicholas T. Bello, Amy L. Walters, Jessica L. Verpeut, Priscila P. Cunha |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Journal of Obesity |
Online Access: | http://dx.doi.org/10.1155/2013/457047 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Viloxazine, a Non-stimulant Norepinephrine Reuptake Inhibitor, for the Treatment of Attention Deficit Hyperactivity Disorder: A 3 Year Update
by: Hannah W Haddad, et al.
Published: (2022-07-01) -
Ankle edema after administration of selective serotonin reuptake inhibitors
by: Konstantinos Kontoangelos, et al.
Published: (2018-06-01) -
Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
by: Orna Diav-Citrin, et al.
Published: (2012-01-01) -
Use of oral midodrine for weaning off norepinephrine in patients with septic shock
by: Mohamed Obaya, et al.
Published: (2025-01-01) -
A High-Fat Diet Causes Impairment in Hippocampal Memory and Sex-Dependent Alterations in Peripheral Metabolism
by: Erica L. Underwood, et al.
Published: (2016-01-01)